Inhaled Tobramycin in BPD

Clinical trial NCT04560179 · COMPLETED

Trial details

NCT number: NCT04560179
Sponsor: Erik Allen Jensen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bronchopulmonary Dysplasia

Start date: 2022-03-22
Primary completion: 2023-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.